Skip to main content
Signal8
Launch Terminal
Williams Paul Anthony profile photo

Paul Anthony Williams

CIK: 0001961994

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (21.4%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (21.4%)

Compensation grants

Other (G, F, J, C, D, …)8 (57.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Emergent BioSolutions Inc. logo
EBS

Emergent BioSolutions Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (14 total)

  • Emergent BioSolutions Inc. logo
    EBS

    Emergent BioSolutions Inc.

    Oct 1, 2026
    Sale(S)
    Direct
    3K shares at avg. $6.53$20K
  • Emergent BioSolutions Inc. logo
    EBS

    Emergent BioSolutions Inc.

    Jul 1, 2026
    Sale(S)
    Direct
    3K shares at avg. $8.40$25K
  • Emergent BioSolutions Inc. logo
    EBS

    Emergent BioSolutions Inc.

    Jun 8, 2026
    Tax Payment(F)
    Direct
    694 shares at avg. $8.00$6K
  • Emergent BioSolutions Inc. logo
    EBS

    Emergent BioSolutions Inc.

    Apr 29, 2026
    Award(A)
    Direct
    100.1K shares-
  • Emergent BioSolutions Inc. logo
    EBS

    Emergent BioSolutions Inc.

    Apr 1, 2026
    Sale(S)
    Direct
    4K shares at avg. $8.44$34K
  • Emergent BioSolutions Inc. logo
    EBS

    Emergent BioSolutions Inc.

    Mar 5, 2026
    Tax Payment(F)
    Direct
    9.4K shares at avg. $8.44$79K
  • Emergent BioSolutions Inc. logo
    EBS

    Emergent BioSolutions Inc.

    Mar 3, 2026
    Award(A)

    Employee Stock Option (Right to buy)

    Direct
    44.8K shares-
  • Emergent BioSolutions Inc. logo
    EBS

    Emergent BioSolutions Inc.

    Mar 1, 2026
    Tax Payment(F)
    Direct
    116 shares at avg. $8.15$945.4
  • Emergent BioSolutions Inc. logo
    EBS

    Emergent BioSolutions Inc.

    Feb 6, 2026
    Tax Payment(F)
    Direct
    1K shares at avg. $10.92$11K
  • Emergent BioSolutions Inc. logo
    EBS

    Emergent BioSolutions Inc.

    Feb 6, 2026
    Disposition(D)
    Direct
    8.7K shares at avg. $10.92$95K
  • Emergent BioSolutions Inc. logo
    EBS

    Emergent BioSolutions Inc.

    Jun 8, 2025
    Tax Payment(F)
    Direct
    464 shares at avg. $6.63$3K
  • Emergent BioSolutions Inc. logo
    EBS

    Emergent BioSolutions Inc.

    Mar 6, 2025
    Award(A)
    Direct
    62.5K shares-
  • Emergent BioSolutions Inc. logo
    EBS

    Emergent BioSolutions Inc.

    Mar 1, 2025
    Tax Payment(F)
    Direct
    116 shares at avg. $7.48$867.68
  • Emergent BioSolutions Inc. logo
    EBS

    Emergent BioSolutions Inc.

    Feb 28, 2025
    Tax Payment(F)
    Direct
    382 shares at avg. $7.48$3K

1-14 of 14

About Williams Paul Anthony

Williams Paul Anthony (SEC CIK 0001961994) files insider reports with the SEC as SVP, Products Business of Emergent BioSolutions Inc. (EBS).

Signal8 holds 11 ownership filings by Williams Paul Anthony, all Form 4s, filed between Mar 4, 2025 and Oct 5, 2026. Those filings report 14 transactions, from Feb 28, 2025 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Williams Paul Anthony's filings is in GAITHERSBURG, MD.

Recent filings by Williams Paul Anthony

  • Oct 1, 2026: Open-market sale of EBS shares (Form 4, code S).
  • Jul 1, 2026: Open-market sale of EBS shares (Form 4, code S).
  • Jun 8, 2026: Tax withholding of EBS shares (Form 4, code F).
  • Apr 29, 2026: Grant or award of EBS shares (Form 4, code A).
  • Apr 1, 2026: Open-market sale of EBS shares (Form 4, code S).

Other insiders filing for Emergent BioSolutions Inc. (EBS)

How to read Form 4 transaction codes